---
figid: PMC6827047__cancers-11-01618-g001
figtitle: Parallel outline of several physiological roles of the TGFB/p38, mitogen-activated
  protein kinase (MAPK), and P13k/AKT/mTOR signaling pathways
organisms:
- Mus musculus
- Rattus norvegicus
- Citrus trifoliata
- Aesculus hippocastanum
- Homo sapiens
- Canis lupus familiaris
pmcid: PMC6827047
filename: cancers-11-01618-g001.jpg
figlink: /pmc/articles/PMC6827047/figure/cancers-11-01618-f001/
number: F1
caption: 'Parallel outline of several physiological roles of the TGFβ/p38, mitogen-activated
  protein kinase (MAPK), and P13k/AKT/mTOR signaling pathways. The p38 mitogen-activated
  kinase can be activated following upstream cytokine stimulation of the TGFβ pathway,
  which can subsequently activate TP53 in normal physiological conditions. TGFβ activation
  of p38 is not dependent on canonical SMAD signaling, but rather on the TAB/TAK1
  complex and the MKK3/6 mitogen-activated protein kinase kinases. The canonical MAPK
  kinase pathway initiates with an extracellular stimulus in the form of growth factors
  (GFs) that bind and activate receptor tyrosine kinases (RTKs) on the cell membrane.
  Downstream activation of RAS, RAF and MEK in that order converge in the activation
  of the ERK1/2 transcription factor activator. The P13K/AKT/mTOR cascade can also
  be activated via RTKs and RAS, and its main implications are related to metabolic
  signaling and protein synthesis that sustain cell growth. TGFβ: transforming growth
  factor beta 1; p38: p38 kinase; P13k: phosphoinositide-3-kinase; AKT: v-akt murine
  thymoma viral oncogene homolog 1; mTOR: mechanistic target of rapamycin kinase;
  TAB: TGF-beta activated kinase 1 binding protein 2; TAK1: TGF-beta activated kinase
  1; MKK3/6: mitogen-activated protein kinase kinase 3; RAS: small G-protein; RAF:
  Raf oncogene; MEK: MAP kinse-ERK kinase; RTKs: Receptor tyrosine kinases.'
papertitle: 'A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer.'
reftext: Cornelia Braicu, et al. Cancers (Basel). 2019 Oct;11(10):1618.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9445775
figid_alias: PMC6827047__F1
figtype: Figure
organisms_ner:
- Canis lupus familiaris
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC6827047__F1
ndex: 1ce88ba6-def4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6827047__cancers-11-01618-g001.html
  '@type': Dataset
  description: 'Parallel outline of several physiological roles of the TGFβ/p38, mitogen-activated
    protein kinase (MAPK), and P13k/AKT/mTOR signaling pathways. The p38 mitogen-activated
    kinase can be activated following upstream cytokine stimulation of the TGFβ pathway,
    which can subsequently activate TP53 in normal physiological conditions. TGFβ
    activation of p38 is not dependent on canonical SMAD signaling, but rather on
    the TAB/TAK1 complex and the MKK3/6 mitogen-activated protein kinase kinases.
    The canonical MAPK kinase pathway initiates with an extracellular stimulus in
    the form of growth factors (GFs) that bind and activate receptor tyrosine kinases
    (RTKs) on the cell membrane. Downstream activation of RAS, RAF and MEK in that
    order converge in the activation of the ERK1/2 transcription factor activator.
    The P13K/AKT/mTOR cascade can also be activated via RTKs and RAS, and its main
    implications are related to metabolic signaling and protein synthesis that sustain
    cell growth. TGFβ: transforming growth factor beta 1; p38: p38 kinase; P13k: phosphoinositide-3-kinase;
    AKT: v-akt murine thymoma viral oncogene homolog 1; mTOR: mechanistic target of
    rapamycin kinase; TAB: TGF-beta activated kinase 1 binding protein 2; TAK1: TGF-beta
    activated kinase 1; MKK3/6: mitogen-activated protein kinase kinase 3; RAS: small
    G-protein; RAF: Raf oncogene; MEK: MAP kinse-ERK kinase; RTKs: Receptor tyrosine
    kinases.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - MTOR
  - EGFR
  - PTEN
  - PDK1
  - TSC2
  - TSC1
  - RHEB
  - MDM2
  - TP53
  - FOS
  - GRB2
  - MAPK1
  - TGFB1
  - TGFB2
  - TGFB3
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - KRAS
  - HRAS
  - NRAS
  - PDPK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XYLT2
  - SOS1
  - SOS2
  - MAP3K7
  - NR2C2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPKAP1
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - SLC12A3
  - TESC
  - CCL26
  - RHEBP1
  - MTG1
  - RPTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAP2K3
  - MAP2K6
  - EIF4EBP1
  - RPS6KB1
  - TP63
  - TP73
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - ADCYAP1
  - ADM
  - ADM2
  - AGRP
  - AGT
  - APLN
  - AVP
  - CALCA
  - CALCB
  - CCK
  - CHGA
  - CRH
  - GAL
  - GALP
  - GAST
  - GHRH
  - GHRL
  - GIP
  - GRP
  - HCRT
  - IAPP
  - IGF1
  - IGF2
  - INS
  - KISS1
  - KNG1
  - LEP
  - MLN
  - NMS
  - NMU
  - NPB
  - NPFF
  - NPS
  - NPVF
  - NPW
  - NPY
  - NTS
  - OXT
  - PDYN
  - PENK
  - PMCH
  - PNOC
  - POMC
  - PPY
  - PRL
  - PRLH
  - PTHLH
  - PYY
  - RLN1
  - RLN2
  - RLN3
  - SCT
  - SST
  - TRH
  - UCN
  - UCN2
  - UCN3
  - UTS2
  - VIP
  - NPPA
  - NPPB
  - NPPC
  - EDN1
  - EDN2
  - EDN3
  - TAC1
  - TAC3
  - TAC4
  - GNRH1
  - GNRH2
  - TAB1
  - TAB2
  - TAB3
  - Tgfb1
  - Ltbp1
  - Egf
  - Mtor
  - Egfr
  - Pten
  - ras
  - Hras
  - Kras
  - Rem1
  - Pdk1
  - Pdpk1
  - Pik3r1
  - Nr2c2
  - Map3k7
  - Zhx2
  - Akt1
  - Slc12a3
  - Tsc22d1
  - Tsc2
  - Tsc1
  - Rheb
  - Mdm2
  - Mdk
  - Map2k3
  - Map2k6
  - Eif4ebp1
  - Rps6kb1
  - Mapk3
  - Trp53
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Creb1
  - Fos
  - Grb2
  - Mapk1
  - Pik3cg
  - Pck1
  - Tp53
  - Ccne1
  - GDP
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
